Cargando…
GABA(A) Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain—Can the Promiscuity Code Be Cracked?
Many allosteric binding sites that modulate gamma aminobutyric acid (GABA) effects have been described in heteropentameric GABA type A (GABA(A)) receptors, among them sites for benzodiazepines, pyrazoloquinolinones and etomidate. Diazepam not only binds at the high affinity extracellular “canonical”...
Autores principales: | Iorio, Maria Teresa, Vogel, Florian Daniel, Koniuszewski, Filip, Scholze, Petra, Rehman, Sabah, Simeone, Xenia, Schnürch, Michael, Mihovilovic, Marko D., Ernst, Margot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982053/ https://www.ncbi.nlm.nih.gov/pubmed/31947863 http://dx.doi.org/10.3390/ijms21010334 |
Ejemplares similares
-
Molecular tools for GABA(A) receptors: High affinity ligands for β1-containing subtypes
por: Simeone, Xenia, et al.
Publicado: (2017) -
Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels
por: Koniuszewski, Filip, et al.
Publicado: (2022) -
Tricyclic antipsychotics and antidepressants can inhibit α5‐containing GABA(A) receptors by two distinct mechanisms
por: Bampali, Konstantina, et al.
Publicado: (2022) -
A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro
por: Steudle, Friederike, et al.
Publicado: (2020) -
Novel pyrazolothienopyridinones as potential GABA(A) receptor modulators
por: Vega Alanis, Blanca Angelica, et al.
Publicado: (2023)